Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112794810B details a scalable photochemical method for cyclobutylamine compounds, offering improved yields and stereocontrol for reliable pharmaceutical intermediate supply chains.
Patent CN101665394B reveals a cost-effective one-pot method for alpha-fluoroacetophenone using eutectics, offering significant supply chain and purity advantages for pharmaceutical manufacturers.
Patent CN1176903C reveals a novel catalytic hydrogenation route for N-[(S)-1-carboxybutyl]-S-alanine ester, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN104086439A offers green recovery for pregabalin intermediates reducing waste and cost for reliable pharmaceutical intermediates supplier partnerships.
Novel diazotization-hydrolysis route for high-purity intermediates. Reduces waste and cost for fluorescent whitener production via scalable chemistry.
Novel enzymatic and cobalt-catalyzed route for antiviral intermediate. Reduces toxicity, improves safety, ensures reliable supply chain for pharmaceutical manufacturing.
Patent CN102212081B details a novel asymmetric synthesis for statin side chains, offering high purity and eliminating resolution steps for cost-effective manufacturing.
Novel Ag-catalyzed cyanoalkylation method solves photocatalysis scale-up issues. Delivers high-purity pharmaceutical intermediates with cost-effective manufacturing.
Advanced synthesis of DO3A via Gd-complexation purification. Eliminates chromatography for cost reduction in pharmaceutical intermediate manufacturing and reliable supply.
Patent CN102690252B details a novel Stiripentol synthesis route converting synthesis by-products into high-value epilepsy intermediates, offering significant cost and supply chain advantages.
Novel five-step route for milabelin intermediate ensures high purity and yield. Reliable pharmaceutical intermediates supplier offering cost reduction in API manufacturing.
Patent CN105061393B reveals a novel route for (S)-(-)-3-methylamino-1-(2-thienyl)-1-propanol, offering >99% purity and >80% yield for scalable duloxetine production.
Novel patent CN114671782A details a scalable synthesis of chiral halohydrin amines from L-phenylalanine, offering high purity and cost-effective manufacturing for antiviral intermediates.
Patent CN111909031B reveals a novel electrochemical defluorinative carboxylation method. Discover cost-effective routes for high-purity pharmaceutical intermediates and agrochemical building blocks.
Patent CN105272792A reveals nickel-catalyzed Suzuki coupling for difluoromethylene compounds. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN110520403B details a ruthenium-catalyzed route minimizing dimer impurities. This breakthrough offers cost reduction in fine chemical manufacturing and reliable supply chain continuity.
Patent CN106146543A details efficient Rh-catalyzed synthesis of chiral alpha-amino tertiary borates, offering cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN103073456B details a high-purity stereoselective synthesis for rivastigmine intermediates, offering significant cost reduction in API manufacturing and scalable production.
Novel resolution method for argatroban starting material improves purity and yield. Offers supply chain stability and cost efficiency for pharmaceutical manufacturing.
Advanced patent CN106146543A enables efficient synthesis of chiral alpha-amino tertiary borates. High enantioselectivity and scalable process for pharmaceutical intermediates.